BIOF · XBRL financial data

Blue Biofuels financial statements, every quarter

The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (BIOF's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Research and development	294	109*	608	291	411	1,020*	351	471	486	997*	385	431
General and administrative	219	396*	296	250	237	944*	338	431	351	290*	275	397
Total operating expenses	513	505*	904	541	648	1,964*	689	903	836	1,287*	659	731
Operating income (loss)	(513)	(505)*	(904)	(541)	(648)	(1,964)*	(689)	(903)	(836)	(1,287)*	(659)	(731)
Interest expense	—	—	—	—	—	—	—	18	—	—	4	20
Other income (expense)	—	—	(1)	(1)	(0)	—	0	0	0	—	—	—
Net income (loss)	(332)	(505)*	(947)	(549)	1,866	(1,789)*	(244)	(921)	(423)	(1,287)*	(664)	(751)
Earnings per share, basic USD per share	(0.00)	0.00*	(0.00)	(0.00)	0.01	(0.01)*	(0.00)	(0.00)	(0.00)	0.00*	(0.00)	(0.00)
Earnings per share, diluted USD per share	(0.00)	—	(0.00)	(0.00)	0.01	(0.01)*	(0.00)	(0.00)	(0.00)	0.00*	(0.00)	(0.00)
Weighted average shares, basic thousands of shares	302,751	304,259*	302,788	302,848	303,143	306,603*	308,460	310,048	312,168	317,978*	319,226	321,220
Weighted average shares, diluted thousands of shares	302,751	250,661*	302,788	302,848	316,852	292,895*	308,460	310,048	312,168	317,978*	319,226	321,220

Fiscal quarters (BIOF's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	85	41	24	408	149	49	8	8	95	65	9	22
Total current assets	254	77	57	440	216	81	40	19	107	77	20	34
Property and equipment, net	612	587	557	528	498	540	642	616	585	555	525	530
Right-of-use asset	105	81	57	32	460	440	422	404	385	365	346	325
Total assets	1,250	1,030	977	1,305	1,489	1,390	1,483	1,448	1,486	1,407	1,310	1,321
Total current liabilities	1,320	1,503	2,068	1,990	1,959	2,212	2,330	2,450	2,393	2,984	3,119	3,375
Lease liability, non-current	9	—	—	—	391	373	354	334	314	293	272	249
Total liabilities	4,342	4,591	5,196	6,058	4,001	4,235	4,434	4,620	4,544	5,113	5,246	5,380
Accumulated deficit	(55,332)	(55,837)	(56,784)	(57,332)	(55,466)	(57,256)	(57,500)	(58,420)	(58,843)	(60,130)	(60,794)	(61,545)
Total stockholders' equity	(3,092)	(3,561)	(4,219)	(4,753)	(2,512)	(2,846)	(2,952)	(3,172)	(3,057)	(3,706)	(3,937)	(4,059)
Total liabilities and equity	1,250	1,030	977	1,305	1,489	1,390	1,483	1,448	1,486	1,407	1,310	1,321
Common shares outstanding (cover page) thousands of shares	302,751	303,116	302,803	303,178	305,678	308,630	309,130	313,200	315,723	320,308	320,948	324,169

Fiscal quarters (BIOF's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(332)	(505)*	(947)	(549)	1,866	(1,789)*	(244)	(921)	(423)	(1,287)*	(664)	(751)
Stock-based compensation	0*	(0)*	279	30	135	1,206*	88	351	259	259*	77	389*
Net cash from operating activities	(314)*	(106)*	(256)	(288)*	(248)*	(212)*	13	(312)*	(154)*	(392)*	(419)	(269)*
Purchases of property and equipment	0*	6*	—	—	—	year only	105	32*	(67)*	(0)*	—	—
Net cash from investing activities	(13)*	(13)*	(21)	1*	(10)*	(86)*	(155)	(39)*	66*	(10)*	(10)	(48)*
Proceeds from issuing common stock	325*	0*	—	—	—	year only	—	—	175*	310*	227	120*
Repayments of long-term debt	—	0*	—	—	—	—	—	—	—	—	—	—
Net cash from financing activities	350*	75*	260	670*	0*	197*	100	351*	175*	373*	372	330*
Net change in cash	23*	(44)*	(17)	383*	(258)*	(101)*	(41)	0*	87*	(30)*	(57)	13*

SIC 2860 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2860 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Blue Biofuels	22	not reported	(269)*	324.2M	0.1 quarters	Q2 FY26 10-QJun 30, 2026
LanzaTech Global	44,977	9,014	(1,388)*	13.1M	32.4 quarters	Q2 FY26 10-QJun 30, 2026
Greenway Technologies, Inc. & Subsidiaries	0.5	not reported	(54)*	464.9M	0.0 quarters	Q2 FY26 10-QJun 30, 2026
Highwater Ethanol	34,875	39,093	15,995*	4,749	—	Q3 FY26 10-QJul 31, 2026
Verde Clean Fuels	53,454	not reported	(826)*	not reported	64.7 quarters	Q2 FY26 10-QJun 30, 2026
Origin Materials	19,191	477	(4,867)	5.5M	6.7 quarters	Q1 FY26 10-QMar 31, 2026
Alto Ingredients	23,962	245,698	28,479*	77.6M	—	Q2 FY26 10-QJun 30, 2026
TOMI Environmental Solutions	322	2,247	(1,594)*	8.1M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
XCF Global	329	691	(6,351)*	410.8M	0.1 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.